Clinical Trial Update: Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating [177Lu] Lu-XT033 Injection for metastatic prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [177Lu] Lu-XT033 Injection

Snippet

Sponsor: Sinotau Pharmaceutical Group | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING